Michael Dowling Named America’s Most Influential Health Care Leader

Northwell Health President and CEO Michael Dowling, who championed innovation to combat the COVID-19 pandemic and was just as aggressive toward health equity and gun violence as a public health crisis, has been selected as America’s most influential leader in health care by Modern Healthcare.

The respected industry publication announced its annual list of the “100 Most Influential People in Healthcare” in its December 5 issue, selecting Mr. Dowling No. 1, ahead of national brand leaders from the likes of CVS Health, UnitedHealthcare and Moderna as well as President Joe Biden (9th) and Xavier Becerra, secretary of the U.S. Department of Health and Human Services (11th).

Modern Healthcare’s ranking is determined by peers and the publication’s editors based on leadership and impact. This represents Mr. Dowling’s 16th year on the Modern Healthcare list; he ranked second nationally in 2020 and third last year.

“The past year had been one in which disrupters turned into major players and industry leaders raised their voices to effect change within their organizations and the broader community,” said Mary Ellen Podmolik, editor of Modern Healthcare. “Our 2022 ranking of the ‘100 Most Influential People in Healthcare’ recognizes these individuals who are transforming a major sector of the nation’s economy and are focused on improving care and payment models.”

As leader of New York State’s largest health care provider and private employer, Mr. Michael Dowling guided Northwell Health through the darkest days of the First Wave and then worked to upend health inequalities laid bare by the pandemic. One of those initiatives became reality in 2022 when Northwell Health unveiled its Center for Maternal Health. Its goal is to improve maternal health, particularly in underserved communities, by focusing on the continuum of care while addressing health conditions that can occur from pre-conception through the first year after delivery.

“This remarkable recognition truly is a reflection of the collaboration and work ethic elicited by thousands of Northwell team members who deliver compassionate care to our patients each and every day,” said Mr. Dowling. “Of course, our daily focus is on our sickest patients. But to serve our broader community, we also look at health trends both looming on the horizon and lurking under the cover of darkness. That’s why we’ve taken a stand against gun violence. That’s why we’ve opened Northwell’s Center for Maternal Health to reduce maternal mortality, especially among black Americans.”

Northwell has also looked beyond borders to offer aid where it’s needed most. The health system donated supplies to Ukraine – embroiled in an unprovoked war with Russia since February – aligned efforts with Doctors Without Borders and offered telehealth equipment and expert support to aid the frontline.

Finally, Northwell continued its mission of shining a light on gun violence in 2022 by launching an advocacy campaign to ensure that guns in homes with children are locked and out of harm’s way. Northwell launched its Center for Gun Violence Prevention in 2020 on the heels of hosting its first forum on the issue in 2019. Guns are now the No. 1 cause of death among Americans 19 and younger.

To see Modern Healthcare’s Top 100, go to: https://www.modernhealthcare.com/awards/100-most-influential-people-healthcare-2022

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy